cobas b 101 system

DESCRIPTION

• Offering combined monitoring of patients’ long-term glucose control and key
  blood lipids levels (high-density and low-density lipoprotein cholesterol, as
  well as triglycerides), cobas b 101 system measures two major indicators that
  aid in the diagnosis of metabolic syndrome.
• The testing of glycated hemoglobin (HbA1c) supports appropriate monitoring
  and treatment by identifying people with high blood glucose levels.
• Blood lipid panel testing allows doctors to determine whether a patient is at
  increased risk of heart and blood vessel disease.
• Highly elevated low-density lipoprotein (LDL) cholesterol and triglyceride
  concentrations in the blood may lead to the accumulation of cholesterol on
  the artery walls.